Press Releases August 27, 2026 04:51 PM

LeMaitre to Participate at Upcoming Investor Conferences in September

LeMaitre Vascular to Present at Multiple Investor Conferences in September

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
LMAT

LeMaitre Vascular, a provider of vascular devices for treating peripheral vascular disease, announced that its CFO, Dorian LeBlanc, will participate in three upcoming investor conferences in September 2026. This includes events hosted by Wells Fargo, Morgan Stanley, and Barrington Research. The company aims to engage with investors and provide updates on its business prospects.

LeMaitre to Participate at Upcoming Investor Conferences in September
LMAT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • LeMaitre Vascular's CFO will participate in three prominent healthcare investor conferences in September 2026.
  • The company specializes in devices for peripheral vascular disease, impacting vascular surgery and medical device sectors.
  • Investor engagement activities may provide updates on company strategy and growth in the healthcare sector.

BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

Wells Fargo 21st Annual Healthcare Conference
Tuesday, September 8, 2026, in Boston
Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET

Morgan Stanley 24th Annual Global Healthcare Conference
Wednesday, September 16, 2026, in New York City
Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET

19th Annual Barrington Research Virtual Fall Investment Conference
Tuesday, September 22, 2026
Dorian LeBlanc, CFO, time to be announced

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
[email protected]


Risks

  • Conference presentations may not reveal significant new information, limiting impact on investor sentiment.
  • Peripheral vascular device market is competitive and subject to regulatory and reimbursement risks.
  • Broader healthcare sector volatility may influence investor reaction despite company-specific news.

More from Press Releases

Koss Corporation Releases Fourth Quarter and Full Year Results Aug 27, 2026 Hooker Furnishings to Host Second Quarter Earnings Call September 11th Aug 27, 2026 NVIDIA Announces Upcoming Event for Financial Community Aug 27, 2026 McEwen Copper Completes US$240 Million Term Loan to Advance Los Azules Toward Final Investment Decision Aug 27, 2026 Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine Aug 27, 2026